nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—COMT—schizophrenia	0.729	1	CbGaD
Methyldopa—DDC—telencephalic ventricle—schizophrenia	0.0122	0.153	CbGeAlD
Methyldopa—DDC—pineal body—schizophrenia	0.0106	0.133	CbGeAlD
Methyldopa—COMT—telencephalic ventricle—schizophrenia	0.00809	0.101	CbGeAlD
Methyldopa—DDC—blood plasma—schizophrenia	0.00584	0.0731	CbGeAlD
Methyldopa—COMT—blood plasma—schizophrenia	0.00386	0.0483	CbGeAlD
Methyldopa—DDC—forebrain—schizophrenia	0.0032	0.04	CbGeAlD
Methyldopa—Metyrosine—TH—schizophrenia	0.00306	0.383	CrCbGaD
Methyldopa—DDC—telencephalon—schizophrenia	0.00294	0.0368	CbGeAlD
Methyldopa—COMT—forebrain—schizophrenia	0.00211	0.0265	CbGeAlD
Methyldopa—DDC—midbrain—schizophrenia	0.00211	0.0264	CbGeAlD
Methyldopa—ADRA2A—blood plasma—schizophrenia	0.00196	0.0246	CbGeAlD
Methyldopa—COMT—telencephalon—schizophrenia	0.00194	0.0243	CbGeAlD
Methyldopa—DDC—endocrine gland—schizophrenia	0.00185	0.0232	CbGeAlD
Methyldopa—DDC—nervous system—schizophrenia	0.00174	0.0217	CbGeAlD
Methyldopa—DDC—central nervous system—schizophrenia	0.00167	0.0209	CbGeAlD
Methyldopa—COMT—gonad—schizophrenia	0.00162	0.0203	CbGeAlD
Methyldopa—COMT—blood—schizophrenia	0.00141	0.0177	CbGeAlD
Methyldopa—COMT—midbrain—schizophrenia	0.0014	0.0175	CbGeAlD
Methyldopa—SLC15A1—endocrine gland—schizophrenia	0.00138	0.0173	CbGeAlD
Methyldopa—DDC—brain—schizophrenia	0.00133	0.0166	CbGeAlD
Methyldopa—COMT—endocrine gland—schizophrenia	0.00123	0.0154	CbGeAlD
Methyldopa—COMT—nervous system—schizophrenia	0.00115	0.0144	CbGeAlD
Methyldopa—COMT—central nervous system—schizophrenia	0.0011	0.0138	CbGeAlD
Methyldopa—COMT—cerebellum—schizophrenia	0.00108	0.0135	CbGeAlD
Methyldopa—ADRA2A—forebrain—schizophrenia	0.00108	0.0135	CbGeAlD
Methyldopa—ADRA2A—telencephalon—schizophrenia	0.00099	0.0124	CbGeAlD
Methyldopa—COMT—brain—schizophrenia	0.000877	0.011	CbGeAlD
Methyldopa—ADRA2A—gonad—schizophrenia	0.000826	0.0103	CbGeAlD
Methyldopa—ADRA2A—blood—schizophrenia	0.00072	0.00902	CbGeAlD
Methyldopa—ADRA2A—midbrain—schizophrenia	0.000711	0.0089	CbGeAlD
Methyldopa—ADRA2A—endocrine gland—schizophrenia	0.000624	0.00782	CbGeAlD
Methyldopa—ADRA2A—nervous system—schizophrenia	0.000584	0.00732	CbGeAlD
Methyldopa—Norepinephrine—SLC18A2—schizophrenia	0.00057	0.0712	CrCbGaD
Methyldopa—ADRA2A—central nervous system—schizophrenia	0.000563	0.00705	CbGeAlD
Methyldopa—ADRA2A—cerebellum—schizophrenia	0.00055	0.00689	CbGeAlD
Methyldopa—ADRA2A—brain—schizophrenia	0.000447	0.00559	CbGeAlD
Methyldopa—Dopamine—COMT—schizophrenia	0.000338	0.0422	CrCbGaD
Methyldopa—L-DOPA—DRD4—schizophrenia	0.000295	0.0368	CrCbGaD
Methyldopa—Dopamine—DRD4—schizophrenia	0.000274	0.0342	CrCbGaD
Methyldopa—Dopamine—MAOA—schizophrenia	0.000255	0.0319	CrCbGaD
Methyldopa—L-DOPA—DRD3—schizophrenia	0.000254	0.0318	CrCbGaD
Methyldopa—Dopamine—HTR7—schizophrenia	0.000251	0.0314	CrCbGaD
Methyldopa—L-DOPA—DRD1—schizophrenia	0.000249	0.0312	CrCbGaD
Methyldopa—Dopamine—DRD3—schizophrenia	0.000236	0.0295	CrCbGaD
Methyldopa—Dopamine—DRD1—schizophrenia	0.000232	0.029	CrCbGaD
Methyldopa—Dopamine—SLC6A3—schizophrenia	0.00022	0.0275	CrCbGaD
Methyldopa—Epinephrine—TNF—schizophrenia	0.000199	0.0249	CrCbGaD
Methyldopa—Dopamine—HTR1A—schizophrenia	0.000193	0.0241	CrCbGaD
Methyldopa—Norepinephrine—DRD2—schizophrenia	0.000176	0.022	CrCbGaD
Methyldopa—L-DOPA—DRD2—schizophrenia	0.000176	0.022	CrCbGaD
Methyldopa—Dopamine—SLC6A4—schizophrenia	0.000164	0.0205	CrCbGaD
Methyldopa—Dopamine—DRD2—schizophrenia	0.000163	0.0204	CrCbGaD
Methyldopa—Norepinephrine—CYP1A2—schizophrenia	0.000161	0.0201	CrCbGaD
Methyldopa—Dopamine—CYP1A2—schizophrenia	0.00015	0.0187	CrCbGaD
Methyldopa—Epinephrine—CYP1A2—schizophrenia	0.000146	0.0183	CrCbGaD
Methyldopa—L-DOPA—CYP2D6—schizophrenia	0.000124	0.0155	CrCbGaD
Methyldopa—Dopamine—CYP2D6—schizophrenia	0.000115	0.0144	CrCbGaD
Methyldopa—ADRA2A—Platelet Aggregation (Plug Formation)—AKT1—schizophrenia	6.51e-05	0.000356	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PRKD1—schizophrenia	6.48e-05	0.000354	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—schizophrenia	6.46e-05	0.000354	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—schizophrenia	6.46e-05	0.000354	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—SLC6A3—schizophrenia	6.46e-05	0.000353	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GRM5—schizophrenia	6.42e-05	0.000351	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—CNR1—schizophrenia	6.3e-05	0.000344	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PRODH—schizophrenia	6.29e-05	0.000344	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—schizophrenia	6.22e-05	0.00034	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR7—schizophrenia	6.14e-05	0.000336	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—schizophrenia	6.14e-05	0.000336	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—schizophrenia	6.13e-05	0.000335	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GAPDH—schizophrenia	6.09e-05	0.000333	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CLOCK—schizophrenia	6.03e-05	0.00033	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL3RA—schizophrenia	6.02e-05	0.000329	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DGKI—schizophrenia	6.01e-05	0.000329	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2C—schizophrenia	6.01e-05	0.000329	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—schizophrenia	6.01e-05	0.000329	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TPH2—schizophrenia	5.88e-05	0.000322	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CACNB2—schizophrenia	5.88e-05	0.000322	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCK—schizophrenia	5.87e-05	0.000321	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—schizophrenia	5.82e-05	0.000318	CbGpPWpGaD
Methyldopa—DDC—Metabolism—DPYD—schizophrenia	5.79e-05	0.000317	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—schizophrenia	5.65e-05	0.000309	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—TP53—schizophrenia	5.64e-05	0.000309	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CCKAR—schizophrenia	5.63e-05	0.000308	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—schizophrenia	5.5e-05	0.000301	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PPP1R1B—schizophrenia	5.5e-05	0.000301	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADORA2A—schizophrenia	5.46e-05	0.000299	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GAPDH—schizophrenia	5.41e-05	0.000296	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—schizophrenia	5.39e-05	0.000295	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CACNA1C—schizophrenia	5.38e-05	0.000294	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CLOCK—schizophrenia	5.36e-05	0.000293	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—TAAR6—schizophrenia	5.3e-05	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GRM2—schizophrenia	5.3e-05	0.00029	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR7—schizophrenia	5.26e-05	0.000288	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—schizophrenia	5.26e-05	0.000288	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PIK3C2A—schizophrenia	5.24e-05	0.000287	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TPH2—schizophrenia	5.22e-05	0.000286	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CACNB2—schizophrenia	5.22e-05	0.000286	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—YWHAZ—schizophrenia	5.17e-05	0.000283	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—ABCB1—schizophrenia	5.17e-05	0.000283	CbGpPWpGaD
Methyldopa—COMT—Metabolism—DPYD—schizophrenia	5.14e-05	0.000281	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MPC2—schizophrenia	5.13e-05	0.000281	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—FZD3—schizophrenia	5.11e-05	0.00028	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPY—schizophrenia	5.1e-05	0.000279	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR1B—schizophrenia	4.92e-05	0.000269	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OXT—schizophrenia	4.92e-05	0.000269	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NGEF—schizophrenia	4.9e-05	0.000268	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GRM2—schizophrenia	4.81e-05	0.000263	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—TAAR6—schizophrenia	4.81e-05	0.000263	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PPP3CC—schizophrenia	4.81e-05	0.000263	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NTS—schizophrenia	4.79e-05	0.000262	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CACNA1C—schizophrenia	4.78e-05	0.000261	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLCH2—schizophrenia	4.77e-05	0.000261	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR1A—schizophrenia	4.74e-05	0.000259	CbGpPWpGaD
Methyldopa—DDC—Metabolism—SNAP25—schizophrenia	4.7e-05	0.000257	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP2D6—schizophrenia	4.7e-05	0.000257	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—FGA—schizophrenia	4.68e-05	0.000256	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—NPS—schizophrenia	4.67e-05	0.000255	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PIK3C2A—schizophrenia	4.65e-05	0.000255	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2C—schizophrenia	4.58e-05	0.00025	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD1—schizophrenia	4.58e-05	0.00025	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ATP2A2—schizophrenia	4.56e-05	0.00025	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—RGS4—schizophrenia	4.5e-05	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GRM3—schizophrenia	4.5e-05	0.000246	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NDST3—schizophrenia	4.48e-05	0.000245	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—APOA1—schizophrenia	4.48e-05	0.000245	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NGEF—schizophrenia	4.45e-05	0.000243	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD3—schizophrenia	4.43e-05	0.000242	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR6—schizophrenia	4.42e-05	0.000242	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NTS—schizophrenia	4.35e-05	0.000238	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—schizophrenia	4.3e-05	0.000235	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD4—schizophrenia	4.3e-05	0.000235	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP1A2—schizophrenia	4.25e-05	0.000233	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC27A5—schizophrenia	4.25e-05	0.000232	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ACSL6—schizophrenia	4.25e-05	0.000232	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TH—schizophrenia	4.19e-05	0.000229	CbGpPWpGaD
Methyldopa—COMT—Metabolism—SNAP25—schizophrenia	4.17e-05	0.000228	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP2D6—schizophrenia	4.17e-05	0.000228	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CNR1—schizophrenia	4.11e-05	0.000225	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GRM3—schizophrenia	4.09e-05	0.000224	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—RGS4—schizophrenia	4.09e-05	0.000224	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—APOA1—schizophrenia	4.08e-05	0.000223	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DAO—schizophrenia	4.05e-05	0.000222	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR6—schizophrenia	4.01e-05	0.00022	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR7—schizophrenia	4.01e-05	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD2—schizophrenia	4.01e-05	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CHRM1—schizophrenia	3.9e-05	0.000214	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PNP—schizophrenia	3.89e-05	0.000213	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL3RA—schizophrenia	3.8e-05	0.000208	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP1A2—schizophrenia	3.78e-05	0.000207	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TH—schizophrenia	3.72e-05	0.000204	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—schizophrenia	3.69e-05	0.000202	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS1—schizophrenia	3.65e-05	0.0002	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GRM5—schizophrenia	3.63e-05	0.000199	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NDUFV2—schizophrenia	3.61e-05	0.000198	CbGpPWpGaD
Methyldopa—DDC—Metabolism—COMT—schizophrenia	3.56e-05	0.000195	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DGKI—schizophrenia	3.55e-05	0.000194	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTP1—schizophrenia	3.55e-05	0.000194	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CHRM1—schizophrenia	3.54e-05	0.000194	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOA—schizophrenia	3.54e-05	0.000194	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL3RA—schizophrenia	3.45e-05	0.000189	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIP4K2A—schizophrenia	3.4e-05	0.000186	CbGpPWpGaD
Methyldopa—DDC—Metabolism—ABCB1—schizophrenia	3.36e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCK—schizophrenia	3.32e-05	0.000182	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GRM5—schizophrenia	3.3e-05	0.00018	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PLA2G4A—schizophrenia	3.26e-05	0.000178	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTM1—schizophrenia	3.26e-05	0.000178	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PPP1R1B—schizophrenia	3.25e-05	0.000178	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE4B—schizophrenia	3.23e-05	0.000177	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CCKAR—schizophrenia	3.18e-05	0.000174	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTP1—schizophrenia	3.15e-05	0.000172	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOA—schizophrenia	3.14e-05	0.000172	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADORA2A—schizophrenia	3.09e-05	0.000169	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP26B1—schizophrenia	3.07e-05	0.000168	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FZD3—schizophrenia	3.02e-05	0.000165	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCK—schizophrenia	3.01e-05	0.000165	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ABCB1—schizophrenia	2.98e-05	0.000163	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4B—schizophrenia	2.94e-05	0.000161	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PLA2G4A—schizophrenia	2.89e-05	0.000158	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTM1—schizophrenia	2.89e-05	0.000158	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CCKAR—schizophrenia	2.89e-05	0.000158	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPY—schizophrenia	2.88e-05	0.000158	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—schizophrenia	2.88e-05	0.000158	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GRM2—schizophrenia	2.84e-05	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FES—schizophrenia	2.84e-05	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PPP3CC—schizophrenia	2.84e-05	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TAAR6—schizophrenia	2.84e-05	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLA2G4A—schizophrenia	2.84e-05	0.000155	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2A—schizophrenia	2.81e-05	0.000154	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADORA2A—schizophrenia	2.8e-05	0.000153	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1B—schizophrenia	2.78e-05	0.000152	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OXT—schizophrenia	2.78e-05	0.000152	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TPH1—schizophrenia	2.74e-05	0.00015	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GCLM—schizophrenia	2.74e-05	0.00015	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOE—schizophrenia	2.68e-05	0.000147	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1A—schizophrenia	2.68e-05	0.000146	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—YWHAZ—schizophrenia	2.67e-05	0.000146	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOA1—schizophrenia	2.65e-05	0.000145	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—NPS—schizophrenia	2.64e-05	0.000144	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NGEF—schizophrenia	2.63e-05	0.000144	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPY—schizophrenia	2.62e-05	0.000143	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD1—schizophrenia	2.59e-05	0.000141	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2C—schizophrenia	2.59e-05	0.000141	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PRKD1—schizophrenia	2.57e-05	0.000141	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTS—schizophrenia	2.57e-05	0.000141	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—schizophrenia	2.56e-05	0.00014	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OXT—schizophrenia	2.53e-05	0.000138	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1B—schizophrenia	2.53e-05	0.000138	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD3—schizophrenia	2.5e-05	0.000137	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1A—schizophrenia	2.43e-05	0.000133	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD4—schizophrenia	2.43e-05	0.000133	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RTN4—schizophrenia	2.42e-05	0.000132	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—RGS4—schizophrenia	2.42e-05	0.000132	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GRM3—schizophrenia	2.42e-05	0.000132	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—NPS—schizophrenia	2.39e-05	0.000131	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOE—schizophrenia	2.38e-05	0.00013	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR6—schizophrenia	2.37e-05	0.00013	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOA1—schizophrenia	2.35e-05	0.000129	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD1—schizophrenia	2.35e-05	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2C—schizophrenia	2.35e-05	0.000128	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CNR1—schizophrenia	2.32e-05	0.000127	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—APOA1—schizophrenia	2.31e-05	0.000126	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MAG—schizophrenia	2.29e-05	0.000125	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD3—schizophrenia	2.27e-05	0.000124	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD2—schizophrenia	2.26e-05	0.000124	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR7—schizophrenia	2.26e-05	0.000124	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD4—schizophrenia	2.21e-05	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GAPDH—schizophrenia	2.15e-05	0.000118	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CLOCK—schizophrenia	2.13e-05	0.000116	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CNR1—schizophrenia	2.11e-05	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CHRM1—schizophrenia	2.09e-05	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TPH2—schizophrenia	2.08e-05	0.000114	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CACNB2—schizophrenia	2.08e-05	0.000114	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD2—schizophrenia	2.06e-05	0.000113	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR7—schizophrenia	2.06e-05	0.000113	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DPYD—schizophrenia	2.04e-05	0.000112	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL3RA—schizophrenia	2.04e-05	0.000112	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TLE1—schizophrenia	1.99e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NRG3—schizophrenia	1.99e-05	0.000109	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GFAP—schizophrenia	1.97e-05	0.000108	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GRM5—schizophrenia	1.95e-05	0.000107	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CACNA1C—schizophrenia	1.9e-05	0.000104	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TLE3—schizophrenia	1.89e-05	0.000103	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIK3C2A—schizophrenia	1.85e-05	0.000101	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCK—schizophrenia	1.78e-05	9.74e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4B—schizophrenia	1.74e-05	9.49e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CCKAR—schizophrenia	1.71e-05	9.34e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SNAP25—schizophrenia	1.66e-05	9.08e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP2D6—schizophrenia	1.66e-05	9.08e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADORA2A—schizophrenia	1.66e-05	9.06e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PLA2G4A—schizophrenia	1.63e-05	8.9e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—FGA—schizophrenia	1.59e-05	8.68e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2A—schizophrenia	1.59e-05	8.68e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—AKT1—schizophrenia	1.56e-05	8.53e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPY—schizophrenia	1.55e-05	8.46e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NOTCH4—schizophrenia	1.55e-05	8.46e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ATP2A2—schizophrenia	1.55e-05	8.46e-05	CbGpPWpGaD
Methyldopa—DDC—Metabolism—EP300—schizophrenia	1.53e-05	8.36e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP1A2—schizophrenia	1.5e-05	8.21e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1B—schizophrenia	1.49e-05	8.16e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OXT—schizophrenia	1.49e-05	8.16e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TH—schizophrenia	1.48e-05	8.09e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2A—schizophrenia	1.44e-05	7.88e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1A—schizophrenia	1.44e-05	7.86e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NPS—schizophrenia	1.41e-05	7.74e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD1—schizophrenia	1.39e-05	7.59e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2C—schizophrenia	1.39e-05	7.59e-05	CbGpPWpGaD
Methyldopa—COMT—Metabolism—EP300—schizophrenia	1.36e-05	7.42e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK2—schizophrenia	1.35e-05	7.38e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD3—schizophrenia	1.34e-05	7.35e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—EP300—schizophrenia	1.33e-05	7.27e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD4—schizophrenia	1.3e-05	7.13e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—COMT—schizophrenia	1.26e-05	6.88e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTP1—schizophrenia	1.25e-05	6.85e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOA—schizophrenia	1.25e-05	6.83e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CNR1—schizophrenia	1.25e-05	6.81e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR7—schizophrenia	1.21e-05	6.65e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD2—schizophrenia	1.21e-05	6.65e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ABCB1—schizophrenia	1.18e-05	6.48e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLA2G4A—schizophrenia	1.15e-05	6.29e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTM1—schizophrenia	1.15e-05	6.29e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRL—schizophrenia	1.15e-05	6.28e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—S100B—schizophrenia	1.07e-05	5.85e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ERBB4—schizophrenia	1.02e-05	5.59e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—schizophrenia	1.02e-05	5.56e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLA2G4A—schizophrenia	9.62e-06	5.26e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TP53—schizophrenia	9.52e-06	5.21e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOE—schizophrenia	9.46e-06	5.18e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NRG1—schizophrenia	9.44e-06	5.16e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MEF2C—schizophrenia	9.35e-06	5.12e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOA1—schizophrenia	9.35e-06	5.12e-05	CbGpPWpGaD
Methyldopa—DDC—Metabolism—AKT1—schizophrenia	9.23e-06	5.05e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—YWHAZ—schizophrenia	9.04e-06	4.95e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ERBB3—schizophrenia	8.84e-06	4.84e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2A—schizophrenia	8.51e-06	4.66e-05	CbGpPWpGaD
Methyldopa—COMT—Metabolism—AKT1—schizophrenia	8.2e-06	4.48e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—AKT1—schizophrenia	8.04e-06	4.4e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOE—schizophrenia	7.91e-06	4.33e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOA1—schizophrenia	7.82e-06	4.28e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ESR1—schizophrenia	7.55e-06	4.13e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GSK3B—schizophrenia	6.85e-06	3.75e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—EP300—schizophrenia	5.39e-06	2.95e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AKT1—schizophrenia	5.08e-06	2.78e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AKT1—schizophrenia	4.61e-06	2.52e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EP300—schizophrenia	4.51e-06	2.47e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—AKT1—schizophrenia	3.26e-06	1.78e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TP53—schizophrenia	3.23e-06	1.76e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AKT1—schizophrenia	2.72e-06	1.49e-05	CbGpPWpGaD
